BridgeBio Pharma (2CL.STU) Q2 2026 Earnings

30AprConfirmed
Q1 2026
Next
-0.85
-0.76
-0.67
-0.57

Details

Expected EPS
-0.5733910235999999
Actual EPS
N/A
Surprise EPS
0.57
Surprise Percent
+100%

Description

BridgeBio Pharma (2CL.STU) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts